Titan Medical Inc. (TMDI) has advanced 7.87% at $0.54 in after-hours trading on the last check Friday. The stock of Titan Medical (TMDI) lost -2.15% to complete the last trading session at $0.50. The price range of the company’s shares was between $0.495 and $0.5214. It traded 0.31 million shares, which was below its daily average of 0.58 million shares over 100 days. TMDI’s shares have dropped by -7.52% in the last five days, while they have subtracted -17.93% in the last month. Titan Medical stock surged in extended trades before participating in a significant event.
When and where will Titan Medical be participating?
Titan Medical (TMDI) is a clinical gadget organization settled in Toronto, Ontario with its operations in Chapel Hill, North Carolina. TMDI centers around improving mechanical helped a medical procedure utilizing creative innovation through a solitary passage. The Enos automated single access careful framework is being created with an ergonomic concentration to give a careful encounter that mirrors genuine developments that specialists request and incorporates multi-articulating instruments intended to permit specialists an expanded scope of movement in a restricted space, with smoothness and the capacity to apply the powers important to finish normal careful responsibilities.
Titan Medical (TMDI) is set to introduce an outline of its Enos mechanical single access careful framework at Oppenheimer’s 32nd Annual Healthcare Conference. The occasion will be a virtual financial backer gathering occurring March 15-17, 2022.
- Paul Cataford, TMDI’s break President and CEO, will give an organization outline and take an interest in financial backer gatherings with Stephen Lemieux, Titan’s CFO.
- TMDI’s show is booked for March fifteenth at 3:20 pm ET.
- The show will be accessible by means of a live webcast and replay on the Investor Relations Events part of the organization’s site.
TMDI’s patent efforts
- TMDI has as of late outperformed 200 licenses and patent applications.
- The significant achievement exhibited TMDI’s obligation to be an advancement chief in single access automated helped a medical procedure.
- Ongoing licenses given to the organization include:
- U.S. Configuration Patent No. D940,736 for an automated instrument graphical UI (GUI),
- European Patent No. 2785267 for a clever patient truck,
- U.S. Patent No. 11,179,209 for independent control frameworks, and
- U.S. Patent Nos. 11,166,771 and 11,166,769, each coordinated at ergonomic parts of automated hand regulators.
What makes TMDI outstanding?
The original methodologies and creations seriously position Titan Medical (TMDI) and a large number of them might be of incredible worth to possible associates and accomplices. TMDI has effectively reported licenses of its patent portfolio to outsiders and the organization keeps on assessing choices for geological extension and income-producing open doors.
